View Older Stories View More Recent Stories

Dec 9, 2014 06:55AM Roth Capital Starts The Joint Corp (JYNT) at Buy
Dec 8, 2014 02:23PM Galena's (GALE) GALE-401 More Promising Following Presentation Phase 2 Data at ASH - Roth
Dec 8, 2014 11:22AM Roth 'Encouraged' by Early Signs of BL-8040 Activity in AML; Affirms BioLineRx at 'Buy'
Dec 8, 2014 08:54AM TG Therapeutics's (TGTX) TGR-1202 Keeps Getting Better; Roth Affirms 'Focus Pick' Rating
Dec 8, 2014 07:19AM Roth Capital Starts Sky Solar (SKYS) at Buy
Dec 8, 2014 07:00AM Roth Capital Downgrades LeapFrog (LF) to Neutral
Dec 5, 2014 07:36AM Roth Comments on Celldex (CLDX) Following Initiation of CDX-011 Phase II
Dec 4, 2014 09:58AM Roth Affirms Cytori (CYTX) at 'Buy'; Celution, ADRCs 'de-Risked' in Japan on New Regulatory Measures
Dec 2, 2014 08:21AM Roth Capital Starts Renewable Energy Group (REGI) at Buy
Dec 2, 2014 08:16AM Roth Capital Starts FutureFuel Corp. (FF) at Buy
Dec 2, 2014 07:23AM Roth Capital Starts RSP Permian, Inc. (RSPP) at Buy
Dec 2, 2014 07:22AM Roth Capital Starts Ring Energy, Inc. (REI) at Buy
Dec 2, 2014 06:54AM Roth Capital Starts Clayton Williams Energy (CWEI) at Buy
Dec 2, 2014 06:53AM Roth Capital Starts Callon Petroleum (CPE) at Buy
Dec 1, 2014 02:20PM Regeneron's (REGN) Eylea sBLA Receives Priority Review as DME + Diabetic Retinopathy Treatment; Roth Capital Comments
Dec 1, 2014 11:46AM TG Therapeutics (TGTX) Still 'Focus Pick' at Roth; New Phase 1/1b of TGR-1202 + Imbruvica Announced
Dec 1, 2014 09:54AM Roth Affirms Can-Fite BioPharma (CANF) at 'Buy' Following Q3 Results; Still Sees FY15 as 'Breakout' Year
Dec 1, 2014 06:34AM Roth Capital Starts Dynamic Materials (BOOM) at Buy
Nov 25, 2014 07:59AM Revolution Lighting (RVLT) Prices 8M Common Offering at $1.25/Share
Nov 25, 2014 06:51AM Trina Solar (TSL) Investors are Seeking More Visibility - Roth Capital
Nov 24, 2014 04:20PM Revolution Lighting (RVLT) Announces Common Stock Offering
Nov 20, 2014 12:17PM Streetinsider.com's Hot Lunchtime Reads 11/20: (LB) (AMZN) (REGN) (GS) (FB)
Nov 20, 2014 10:46AM Regeneron's (REGN) Dupilumab Receives FDA Breakthrough Designation; Roth Capital Comments
Nov 20, 2014 08:55AM Roth Updates Model on Trina Solar (TSL) Following Oct. Capital Raise; Affirms 'Buy' Rating
Nov 20, 2014 06:36AM Roth Cuts PT on RGS Energy (RGSE) to 80c Following Q3 Miss, Lack of Guidance
Nov 19, 2014 11:02AM Roth Comments on Regeneron (REGN) Following ODYSSEY Update at AHA (SNY)
Nov 19, 2014 09:55AM Roth is Buyer of JA Solar (JASO) Following Q3 Results; Affirms 'Buy' Rating
Nov 18, 2014 12:26PM Significant Partnership Could be in Store for Can-Fite (CANF) - Roth
Nov 18, 2014 09:28AM Roth Capital Starts New Gold (NGD) at Neutral
Nov 18, 2014 08:22AM Roth Capital Positive on Galena (GALE) Following Quick Enrollment of GALE-401 Phase 2
Nov 18, 2014 06:59AM Roth Capital Comments on Keryx (KERX) Following KOL Panel; Affirms 'Buy' Rating
Nov 17, 2014 10:54AM Notable Analyst Rating Changes 11/17: (MTG) (PSX) (CHK) Upgraded; (NOK) (ODP) (WTSL) Downgraded
Nov 17, 2014 09:42AM Pre-Open Stock Movers 11/17: (CLDX) (BHI) (AGN) Higher; (DWA) (GSAT) (HAL) Lower (more...)
Nov 17, 2014 08:46AM Roth Capital Lifts PT on Celldex (CLDX) to $43 Following Phase 2 ReACT Presentation
Nov 17, 2014 06:39AM Roth Capital Downgrades Hecla Mining (HL) to Neutral
Nov 14, 2014 11:49AM Roth Remains Positive on ImmunoCellular (IMUC) Following ICT-107 Phase 2 Presentation at SNO
Nov 13, 2014 08:55AM Canadian Solar's (CSIQ) Margin Guidance Spooks Investors, Buy Industry Position Remains Strong - Roth
Nov 13, 2014 07:57AM Roth Cuts PT on Plug Power (PLUG) to $4 Following 'Largely Disappointing' Q3 Report
Nov 12, 2014 11:37AM Roth Trims Price Target on Concert (CNCE) to $21; CTP-354 Phase II Delayed on Toxicity Signal
Nov 12, 2014 08:25AM Roth Capital Upgrades Dendreon (DNDN) to Neutral
Nov 11, 2014 12:47PM Roth Comments on Galena (GALE) Following Initiation of Herceptin Combo Trial
Nov 11, 2014 11:31AM Roth Positive on TG Therapeutics (TGTX) Following Q3 Results; Expects Strong ASH Showing
Nov 11, 2014 10:08AM The Joint Corp (JYNT) IPO Opens Slightly Higher
Nov 11, 2014 09:12AM Roth Affirms Sunesis (SNSS) at 'Neutral'; ASH Presentations May Help Clear Cloudy Outlook
Nov 11, 2014 07:50AM Sage (SAGE) SRSE Data is Positive for Ligand Pharma (LGND) - Roth
Nov 11, 2014 07:13AM Roth Capital Downgrades Planar Systems (PLNR) to Neutral
Nov 11, 2014 06:58AM Roth Capital Upgrades ICU Medical (ICUI) to Buy
Nov 10, 2014 02:34PM Roth Affirms Curis (CRIS) at 'Buy' Following Q3 Report, Update; Pipeline Progress is Encouraging
Nov 10, 2014 12:14PM Streetinsider.com's Hot Lunchtime Reads 11/10: (TWTR) (HIMX) (SVU) (AGU)
Nov 10, 2014 11:30AM Roth Capital 'Encouraged' by PoC Data from Celldex's (CLDX) Varlilumab Phase 1
View More Recent Stories View Older Stories